Discovery and engineering of colchicine alkaloid biosynthesis
Few complete pathways have been established for the biosynthesis of medicinal compounds from plants. Accordingly, many plant-derived therapeutics are isolated directly from medicinal plants or plant cell culture . A lead example is colchicine, a US Food and Drug Administration (FDA)-approved treatme...
Saved in:
Published in | Nature (London) Vol. 584; no. 7819; pp. 148 - 153 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
Nature Publishing Group
06.08.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Few complete pathways have been established for the biosynthesis of medicinal compounds from plants. Accordingly, many plant-derived therapeutics are isolated directly from medicinal plants or plant cell culture
. A lead example is colchicine, a US Food and Drug Administration (FDA)-approved treatment for inflammatory disorders that is sourced from Colchicum and Gloriosa species
. Here we use a combination of transcriptomics, metabolic logic and pathway reconstitution to elucidate a near-complete biosynthetic pathway to colchicine without prior knowledge of biosynthetic genes, a sequenced genome or genetic tools in the native host. We uncovered eight genes from Gloriosa superba for the biosynthesis of N-formyldemecolcine, a colchicine precursor that contains the characteristic tropolone ring and pharmacophore of colchicine
. Notably, we identified a non-canonical cytochrome P450 that catalyses the remarkable ring expansion reaction that is required to produce the distinct carbon scaffold of colchicine. We further used the newly identified genes to engineer a biosynthetic pathway (comprising 16 enzymes in total) to N-formyldemecolcine in Nicotiana benthamiana starting from the amino acids phenylalanine and tyrosine. This study establishes a metabolic route to tropolone-containing colchicine alkaloids and provides insights into the unique chemistry that plants use to generate complex, bioactive metabolites from simple amino acids. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 AUTHOR CONTRIBUTIONS R.S.N., W.L., and E.S.S. conceived experiments. R.S.N. and W.L. analyzed transcriptome data, expressed and characterized biosynthetic genes, established the metabolic engineering strategy, and synthesized/isolated authentic chemical standards. W.L. performed the RNA-sequencing experiment and metabolite profiling of G. superba. R.S.N., W.L., and E.S.S. analyzed the data and wrote the manuscript. Contributed equally to this work |
ISSN: | 0028-0836 1476-4687 |
DOI: | 10.1038/s41586-020-2546-8 |